Shubham Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -24.51%
(FY 2022)
- Net Worth -40.52%
(FY 2022)
- Total Assets -96.55%
(FY 2022)
About Shubham Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Punit Popat and Kiritbhai Popat serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC068653
- Company No.
068653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shubham Life Science Private Limited offer?
Shubham Life Science Private Limited offers a wide range of products and services, including Dental Implant Kit, Collagen Sheet, Nutraceuticals & Dietary Supplements, Nutraceuticals, Collagen Membrane, Collagen Supplements.
Who are the key members and board of directors at Shubham Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Punit Popat  | Director | 17-Jan-2012 | Current |
| Kiritbhai Popat | Director | 17-Jan-2012 | Current |
Financial Performance of Shubham Life Science.
Shubham Life Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 24.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shubham Life Science?
In 2017, Shubham Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Adhiya Ventures (India) Private LimitedActive 9 years 4 months
Punit Popat and Kiritbhai Popat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shubham Life Science?
Unlock and access historical data on people associated with Shubham Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubham Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubham Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
